bioRxivBiophysics
High-throughput discovery of inhibitory protein fragments with AlphaFold
Abstract
Peptides can bind to specific sites on larger proteins and thereby function as inhibitors and regulatory elements. Peptide fragments of larger proteins are particularly attractive for achieving these functions due to their inherent potential to form native-like binding interactions. Recently developed experimental approaches allow for high-throughput measurement of protein fragment inhibitory activity in living cells. However, it has thus far not been possible to predict de novo which of the many possible protein fragments bind to protein targets, let alone act as inhibitors. We have developed a computational method, FragFold, that employs AlphaFold to predict protein fragment binding to full-length proteins in a high-throughput manner. Applying FragFold to thousands of fragments tiling across diverse proteins revealed peaks of predicted binding along each protein sequence. Comparisons with experimental measurements establish that our approach is a sensitive predictor of fragment function: Evaluating inhibitory fragments from known protein-protein interaction interfaces, we find 87% are predicted by FragFold to bind in a native-like mode. Across full protein sequences, 68% of FragFold-predicted binding peaks match experimentally measured inhibitory peaks. Deep mutational scanning experiments support the predicted binding modes and uncover superior inhibitory peptides in high throughput. Further, FragFold is able to predict previously unknown protein binding modes, explaining prior genetic and biochemical data. The success rate of FragFold demonstrates that this computational approach should be broadly applicable for discovering inhibitory protein fragments across proteomes. Significance StatementPeptides can regulate protein interactions by binding to specific interfaces, and fragments of larger proteins have high potential to function in this manner. Recently developed experimental methods allow massively parallel measurement of protein fragment-based inhibition in vivo. However, we have lacked comparable computational methods to predict which protein fragments act as inhibitors and how they bind. Here we report a new approach, FragFold, which leverages high-throughput AlphaFold predictions of protein - fragment binding to tackle these problems at scale. FragFold is successful at predicting inhibitory protein fragments and their binding modes across diverse protein structures and functions. This new approach stands to enable proteome-wide discovery of inhibitory protein fragments and aid the interpretation of high-throughput experimental measurements of inhibitory activity. ClassificationBiological Sciences / Biophysics and Computational Biology
- assay: protein structure
- research focus: protein folding & dynamics
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: deep learning
- approach: transformer / foundation model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mapping functional regions of essential bacterial proteins with dominant-negative protein fragments
A. Savinov, A. Fernandez, S. Fields·bioRxiv·Jan 4, 2022
- AlphaFold encodes the principles to identify high affinity peptide binders
- Improving Peptide-Protein Docking with AlphaFold-Multimer using Forced Sampling
Isak Johansson-Åkhe, Björn Wallner·Frontiers in BioinformaticsPeer-reviewed·Sep 26, 2022
- Design of Cyclic Peptides Targeting Protein-Protein Interactions using AlphaFold
Takatsugu Kosugi, Masahito Ohue·International Journal of Molecular SciencesPeer-reviewed·Aug 26, 2023
- Using AlphaFold Multimer to discover interkingdom protein-protein interactions
Felix Homma, Joy Chenqu Lyu, Renier A. L. van der Hoorn·The Plant JournalPeer-reviewed·Aug 17, 2024
- Decoding Surface Fingerprints for Protein-Ligand Interactions
Ilia Igashov, Arian R. Jamasb, … Bruno E. Correia·bioRxiv·Apr 26, 2022